Led by a team of experienced professionals with deep expertise in pharmaceutical development and intellectual property management, BIOSIRIUS Ltd brings together scientific excellence, regulatory knowledge, and commercial acumen. Our leadership combines medical expertise with extensive experience in biotechnology commercialization, ensuring that every licensing decision is grounded in both scientific merit and market viability.

​

Through the collaboration between our clinical, scientific and IP teams, we have secured granted patents for a new treatment method of viral pneumonia in more than 25 countries in Europe, with multiple applications in other jurisdictions, underway. 

​

Contact us for more information.